ALICIA KARAM: Open Payments
NPI 1811549413 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,034 in 210 payments from 18 companies in 2025. Trend: 2023 $3,391 · 2024 $3,253 · 2025 $4,034
Food & beverage: $3,953Education: $81
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $774 |
| Axsome Therapeutics, Inc. | 16 | $463 |
| Otsuka America Pharmaceutical, Inc. | 20 | $385 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $378 |
| Alkermes, Inc. | 19 | $306 |
| Neurocrine BioSciences, Inc. | 20 | $304 |
| E.R. Squibb & Sons, L.L.C. | 11 | $291 |
| Vanda Pharmaceuticals Inc. | 13 | $247 |
| Collegium Pharmaceutical, Inc. | 18 | $235 |
| Teva Pharmaceuticals USA, Inc. | 6 | $177 |
Products named: VRAYLAR, Auvelity, CAPLYTA, INGREZZA, COBENFY, ARISTADA, REXULTI, Jornay PM.
Industry payments across KY — which companies pay providers there.
